Side effects of medical therapy for chronic hepatitis C
The treatment of chronic hepatitis C virus (HCV) has improved greatly over the past decade. Over half of all patients treated with the combination of peginterferon and ribavirin have the opportunity to achieve sustained virologic response. The major factors which interfere with this goal are the sid...
Main Author: | Shiffman Mitchell L, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2004-01-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119321180 |
Similar Items
-
Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
by: Young Kul Jung, et al.
Published: (2013-03-01) -
Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea
by: Suh Yoon Yang, et al.
Published: (2015-06-01) -
The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil
by: Artico Simara, et al.
Published: (2012-12-01) -
Chronic hepatitis C: hepatic iron content does not correlate with response to antiviral therapy Hepatite C crônica: concentração hepática de ferro não é correlacionada com a resposta ao tratamento antiviral
by: Patricia da Silva Fucuta Pereira, et al.
Published: (2009-12-01) -
Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?
by: Woo Sun Rou, et al.
Published: (2015-06-01)